Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Product type
Topic
- Committees and advisory bodies (384)
- Scheduling (national classification system) (166)
- Safety monitoring and information (27)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Type of content
Search
13 result(s) found, displaying 1 to 13
-
Meeting statementsAdvisory Committee on Biologicals meeting statement
-
Meeting statementsAdvisory Committee on Biologicals meeting statement
-
Meeting statementsAdvisory Committee on Biologicals meeting statement
-
Meeting statementsAdvisory Committee on Biologicals meeting statement
-
Corporate reportsThe TGA thanks respondents who provided submissions
-
Corporate reportsReport detailing prescription medicines registrations for 2017
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 6 statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 5 statement
-
Corporate reportsThis statement guides decision making to help address concerns with joint replacement prostheses.
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 4 statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 3 statement
-
Corporate reportsFind out when software is classified as an in vitro medical device and how it is regulated.
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 2 statement